US 11603408
Methods for treating skin infection by administering an IL-4R antagonist
granted A61KA61K2039/505A61K2039/54
Quick answer
US patent 11603408 (Methods for treating skin infection by administering an IL-4R antagonist) held by REGENERON PHARMACEUTICALS, INC. expires Mon Mar 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Mar 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K2039/505, A61K2039/54, A61K39/3955, A61K45/06